MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT05505110
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- C-section
- Microbiome
- Respiratory
- Vaginal Seeding
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- Vaginal Seeding — BIOLOGICALFollowing birth by C-section and immediately after the initial newborn care by the general pediatric team, children randomized to the intervention group will have their nasal cavity swabbed with maternal vaginal secretions.
- Sterile Swab — OTHERFollowing birth by C-section and immediately after the initial newborn care by the general pediatric team, children randomized to the control group will have their nasal cavity swabbed with a sterile swab.
Study Details
This is a single-center, parallel-arm, blind, sham-controlled, feasibility randomized controlled trial (RCT) to be conducted in healthy cesarean-born children. Eligible children will be randomized 1:1 to have their nose swabbed with either maternal vaginal secretions or a sterile swab (intervention vs. control group, respectively). The main hypothesis is that conducting an RCT assessing the utility of vaginal seeding in modifying the early-life upper respiratory tract (URT) microbiome of children born by cesarean section (C-section) is feasible and that the intervention is safe.
Key Dates
- Start date
- Nov 9, 2022
- Status verified
- Nov 2025
- Primary completion
- Aug 10, 2028
- Completion
- Aug 10, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Intervention GroupVaginal Seeding
- Sham Comparator: Control GroupSterile Swab
Primary Outcome Measure
Feasibility of the RCT [ Time Frame: Six months following randomization ]
Central Contacts
- MOTHER SEED Study Team615-936-5552
- Andrea E Lee, MA, MLS615-936-5552
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 |
Find similar trials in Nashville, TN
By research site
Related Studies
- Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIVPHASE2 · Recruiting · University of California, San Diego · San Diego, California
- The Role of Brain-Bone Marrow-Gut Interaction Following Major TraumaRecruiting · University of Florida · Gainesville, Florida
- Enabling Microbiomics- Driven Personalized NutritionEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Smoothie Program for Achieving and Resilient KidsNot Yet Recruiting · Penn State University · State College, Pennsylvania